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Abstract
Purpose Rectal cancer staging with magnetic resonance imaging (MRI) allows accurate assessment and preoperative staging of
rectal cancers. Therefore, complete MRI reports are vital to treatment planning. Significant variability may exist in their content
and completeness. Template-style reporting can improve reporting standards, but its use is not widespread. Given the implica-
tions for treatment, we have evaluated current clinical practice amongst specialist gastrointestinal (GI) radiologists to measure the
quality of rectal cancer staging MRI reports.
Materials and methods Sixteen United Kingdom (UK) colorectal cancer multi-disciplinary teams (CRC-MDTs) serving a
population over 5 million were invited to submit up to 10 consecutive rectal cancer primary staging MRI reports from January
2016 for each radiologist participating in the CRC-MDT. Reports were compared to a reference standard based on recognised
staging and prognostic factors influencing case management
Results Four hundred ten primary staging reports were submitted from 41 of 42 (97.6%) eligible radiologists. Three
hundred sixty reports met the inclusion criteria, of these, 81 (22.5%) used a template. Template report usage significantly
increased recording of key data points versus non-template reports for extra-mural venous invasion (EMVI) status
(98.8% v 51.6%, p < 0.01) and circumferential resection margin (CRM) status (96.3% v 65.9%, p < 0.01). Local tumour
stage (97.5% v 93.5%, NS) and nodal status (98.8% v 96.1%, NS) were reported and with similar frequency.
Conclusion Rectal cancer primary staging reports do not meet published standards. Template-style reports have significant
increases in the inclusion of key tumour descriptors. This study provides further support for their use to improve reporting
standards and outcomes in rectal cancer.
Key Points
• MRI primary staging of rectal cancer requires detailed tumour descriptions as these alter the neoadjuvant and surgical
treatments.
• Currently, rectal cancer MRI reports in clinical practice do not provide sufficient detail on these tumour descriptors.
• The use of template-style reports for primary staging of rectal cancer significantly improves report quality compared to free-text
reports.
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Abbreviations
BSGAR British Society of Gastrointestinal
and Abdominal Radiology
CRC-MDTs Colorectal cancer multi-disciplinary teams
CRM Circumferential resection margin
CRT Chemoradiotherapy
EMVI Extra-mural venous invasion
ESGAR European Society of Gastrointestinal
Abdominal Radiology
GI Gastrointestinal
MRF Mesorectal fascia
MRI Magnetic resonance imaging
SAR Society of Abdominal Radiology
UK United Kingdom
Introduction
Magnetic resonance imaging (MRI) is the most accurate meth-
od of rectal cancer pre-operative staging and re-assessment
[1–4]. Tumour features identified on the rectal cancer baseline
staging MRI (‘primary staging’) determine the subsequent
clinical management including whether neo-adjuvant radio-
therapy or chemoradiotherapy (CRT) is given prior to surgical
resection [1, 5]. Follow-up rectal cancer assessment MRI
(‘restaging’) helps to determine the operative technique or
alternative treatment approaches including the ‘watch and
wait’ approach. The timing of imaging post neo-adjuvant
CRT is debated, but is typically 6–8 weeks after completion
of CRT [1, 5–9]. Imaging reports describe the tumour features
to clinical teams influencing clinical decisions. This empha-
sises the importance of accurate and reproducible primary
staging and restaging MRI reports.
There is increasing interest in structured reporting in radi-
ology and pathology to improve communication of imaging
findings and generating consistent reports, for clarity and con-
tent [10–13]. This applies to rectal MRI reporting with recent
consensus statements published by the European Society of
Gastrointestinal Abdominal Radiology (ESGAR) and Society
of Abdominal Radiology (SAR) both recommending report
templates for primary staging and restaging [14, 15].
Radiological imaging templates have been produced and eval-
uated elsewhere but often these templates have not been wide-
ly adopted, with many radiologists preferring free-text reports
[16, 17]. Across 16 different hospital sites in UK (14 different
NHS trusts) serving our population of 5.7 million, there is
variable usage of template reporting in clinical practice for
primary staging [18].
Across our population of approximately 1000 new rectal
cancer diagnoses per year, we retrospectively evaluated the
current standard of primary staging rectal cancer MRI reports
in clinical practice [19].
Materials and methods
This was a retrospective service evaluation study, so local
ethical approval was waived. This study used only primary
staging reports generated as a routine part of patients care. All
reports were anonymised before entralisation to remove any
patient identifiable information.
Sixteen UK colorectal cancer multi-disciplinary teams
(CRC-MDTs) serving a combined population of over 5.7 mil-
lion in Yorkshire, UK, were invited to participate. The CRC-
MDT lead radiologist at each centre was invited by email to
submit 10 consecutive primary staging reports for each radi-
ologist in their department routinely reporting rectal MRI or
regularly participating in the CRC-MDT. The anonymised
consecutive reports had to be within a 12-month period from
January 2016 until January 2017; therefore, those radiologists
with a small workload of rectal cancer supplied all their pri-
mary staging reports for the year. All radiologists involved are
gastrointestinal (GI) sub-specialists; all have received special-
ist training in rectalMRI and are members of either ESGAR or
BSGAR.
Each site anonymised the clinical information, history and
report content prior to submission. In addition, a coding sys-
tem was employed by the lead radiologist at each site to allow
unbiased analysis of each radiologist’s set of reports, whilst
also allowing individualised feedback via the lead at each site.
Reports were compared by a single investigator to a
reference standard based on key tumour descriptors from
UICC-TNM 5 staging and other recognised factors known
to influence case management that have subsequently
been included in ESGAR and SAR recommendations
[14, 15]. In total, the inclusion of 22 key tumour descrip-
tors was evaluated within each report (Table 1). The in-
clusion of each tumour descriptor, or a comment
confirming a negative finding within each report counted
as ‘reported’. The failure to provide a description of the
presence or absence of a feature in a report counted as
‘not reported’. Some appropriate report exclusions were
allowed depending on the tumour features (e.g. the ab-
sence of a distance through the muscularis propria was
considered acceptable for T1/T2 tumours or not stating
which organs are involved by tumour with T1–3 staging).
Several differing descriptive methods were permitted in
reports for the relationship to the mesorectal fascia
(MRF), and so depth of mesorectal fat invasion; either
an absolute measurement or subcategories (i.e. T3a–d)
and thus the potential risk to the circumferential resection
margin (CRM) status.
To allow comparisons between reporting styles, the tem-
plate or free-text style of reporting was also recorded.
A simple report scoring system for overall report quality
was used based on the accumulated inclusion (or lack) of each
key tumour descriptor giving a maximum score of 22. This
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was adjusted to calculate a ‘completeness’ percentage score
for each reporter which corrected for case sets which appro-
priately excluded a tumour descriptor.
Statistical analysis
All data was tabulated in Microsoft Excel (Office 365,
Microsoft Corp.) and statistical analysis performed using
Stata Statistical Software (Release 15, StataCorp LLC.).
Fisher’s exact test was used to test for statistical significance
in differences in reporting standards between free-text and
template reports. Corrections for multiple testing were per-
formed using Holm’s method of correction [20]; therefore, a
corrected p value < 0.01 was required for consideration of
statistical significance.
Results
Four hundred ten primary staging reports were submitted from
41 of 42 (97.6%) eligible radiologists across the region. One
trust (one radiologist) did not participate. Fifty reports (12.2%)
were excluded; 16 reports as they were not pre-intervention
MRI scans (of these, 14 were re-staging scans and 2 were
baseline scans that acquired post-total excision biopsy), 4
were scans for non-rectal lower gastrointestinal tract tumours
and 2 were rectal MRI for benign indications. A further 28
Table 1 Tumour descriptors collected from each baseline rectal cancer staging MRI
Key tumour descriptor Description of what the tumour descriptor assessed
Tumour Vertical location An indication of ‘lower’, ‘mid’ or ‘upper’ rectum
Length The vertical, unidirectional size of the tumour
Distance from the anal verge Measurement from anal verge to help plan the operation/radiotherapy
Shape A description of the tumour morphology, e.g. annular, semi-annular,
polypoidal, flat
Radial location of wall involvement Inclusion of either a clock-face description or equivalent descriptive term
(e.g. left lateral)
MRI signal A description of the predominant component (i.e. solid or mucinous
tumour type)
Relationship to peritoneal reflection A description of the tumour relative to the peritoneal reflection; above, at
the level of or below
T stage
If ≥ T3 Distance through muscularis propria/T3 subcategory Inclusion of either a direct or indirect measurements; i.e. mm or T3
subcategories; T3a–d
MRF MRF status A description of if the MRF was threatened or involved
If threatened/involved, by what A description of what threatened/involved the MRF; i.e. tumour, EMVI,
lymph node
Minimum distance to the MRF If threatened a measurement was required here, unless involved
Location closest to MRF Inclusion of descriptors of the location closest to the MRF; either a
clock-face description or equivalent descriptive term (e.g. left lateral)
If ≥ T4 Involvement of peritoneum and/or which organs A statement of which organs/ peritoneal involvement
Nodes Nodal status A statement of mesorectal or extra-mesorectal lymph node metastatic
status
If N+, location of involved nodes A description of the involved lymph node location (i.e. mesorectal or
extra-mesorectal)
If N+, radial location of mesorectal nodal involvement A description of the involved lymph node location (i.e. radial location for
surgical planning)
If N+, superior location of node involvement A description of the involved lymph node location (i.e. radial location for
surgical/radiotherapy planning)
EMVI EMVI status A statement of EMVI involvement (i.e. present or not)
EMVI radial and/or superior location A description of the involved lymph node location (e.g. radial location for
surgical planning)
Metastases Distant metastatic status A statement onmetastatic status if liver sequences included in the imaging
protocol or known from other cross-sectional imaging assessment
Overall predicted TNM stage
MRF mesorectal fascia, EMVI extra-mural venous invasion
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‘potential reports’ were not analysed as they fell outside the
1 year data collection window. A total of 360 primary staging
reports were included for analysis (median 10 per radiologist,
Inter-Quartile Range 6–10, range 4–10 reports per radiolo-
gist); 81 (22.5%) were reported using intra-departmental
standardised templates; this involved two different hospital
organisations (a large teaching hospital and smaller district
general hospital), the remaining 279 reports were free-text
reports.
Standard of report contents
There was substantial variability of tumour descriptor inclu-
sion in reports (Table 2). Certain variables were reported in
over 85% of all reports, including vertical location of tumours,
tumour length, tumour and nodal staging and location of in-
volved lymph nodes. However, other tumour descriptors were
included in less than 75% of reports, including radial location
of wall involvement by the tumour, distance through the
muscularis propria (for tumours > T3; 229 reports were of
T3 or T4 tumours), MRF status and extra-mural venous inva-
sion status. The tumour descriptors with the lowest likelihood
of being included in primary staging reports were the tumour
relationship to the peritoneal reflection and location of the
most superior malignant mesorectal lymph node (relative to
the sacral level), which are important surgical and radiothera-
py landmarks respectively.
Impact of template reporting
Further analysis assessing the impact of template reporting
showed statistically significant differences for most tumour
descriptors after correction for multiple testing (Table 3).
The only tumour descriptors with similar rates of inclusion
in reports for free-text and template reports were tumour loca-
tion, T-stage, descriptors of what threatened the MRF (i.e.
Table 2 Tumour descriptors and
their inclusion in the total number
of reports
Total number of reports including
the variable/total number of reports
(%)
Tumour Vertical location 327/360 (91%)
Length 312/360 (87%)
Distance from the anal verge 305/360 (85%)
Shape 260/360 (72%)
Radial location of wall involvement* 156/270 (57%)
MRI signal 114/360 (32%)
Relationship to peritoneal reflection 152/360 (42%)
T stage 340/360 (94%)
If ≥ T3 Distance through muscularis propria* 114/227 (50%)
MRF MRF status 262/360 (73%)
If threatened/involved, by what* 160/167 (96%)
Minimum distance to the MRF* 96/151 (64%)
Location closest to MRF 217/360 (60%)
If ≥ T4 Which organs involved* 75/83 (90%)
Nodes Nodal status 348/360 (97%)
If N+, location of involved nodes* 207/215 (96%)
If N+, radial location of mesorectal nodal
involvement*
125/206 (61%)
If N+, superior location of node involvement* 69/204 (34%)
EMVI EMVI status 224/360 (62%)
EMVI radial and/or superior location* 71/115 (62%)
Metastases Metastatic status* 107/244 (44%)
Overall predicted stage 329/360 (91%)
*Tumour descriptors with appropriate report exclusions allowed depending on the tumour features (e.g. the
absence of a distance through the muscularis propria was considered acceptable for T1/T2 tumours or not stating
which organs are involved by tumour with T1–3 staging, or radial location of wall involvement for annular
tumours)
MRF mesorectal fascia, EMVI extra-mural venous invasion
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tumour or lymph node), nodal status and location of involved
nodes. The remaining tumour descriptors all demonstrated a
statistically significant increase in report inclusion when a
template was used. Most notably, this included relationship
to the MRF that was only included in 184 of 279 (65.9%) of
free-text reports compared to 78 of 81 (96.3%) of template
reports (p < 0.01). Similarly, extra-mural venous invasion sta-
tus was only included in 144 of 279 (51.6%) of the free-text
reports compared to 80 of 81 (98.7%) of the template reports
respectively (p < 0.01).
The median report scoring system demonstrated ‘com-
pleteness’ percentage across all reports was 65% inclusion
of all variables (inter-quartile range, 57–72%). Subgroup anal-
ysis comparing template and free-text report groups demon-
strated a significant improvement (p = 0.039) in the ‘com-
pleteness’ percentage score with template use, a median of
96% inclusion of all variables (IQR, 92–97%) compared to
median 57% inclusion of all variables (IQR, 55–68%) respec-
tively. Figure 1 shows the completeness percentage scores
across all radiologists involved in the study.
Discussion
This study has shown the current standard of primary staging
rectal cancer MRI reports used in clinical practice consistently
omit important information describing tumours. Here, in the
largest study of its type, the use of template reporting has been
shown to significantly improve the inclusion of key tumour
descriptors when compared to free-text reporting in primary
staging. A comparative study where the content of reports has
been audited contains an assessment of only 128 reports and
Table 3 Tumour descriptors and their inclusion on prose and template with statistical differences between the report styles included
Total number of free-text reports
including the variable/total number
of free-text reports (%)
Total number of template reports
including the variable/total number
of template reports (%)
Fisher’s exact
test p value
Critical p
value
Tumour Vertical location 248/279 (89%) 79/81 (98%) 0.0154 0.0100
Length 233/279 (84%) 79/81 (98%) 0.0004 0.0050
Distance from the anal verge 227/279 (81%) 78/81 (96%) 0.0004 0.0056
Shape 181/279 (65%) 79/81 (98%) 0.0000 0.0033
Radial location of wall
involvement*
96/207 (46%) 60/63 (95%) 0.0000 0.0029
MRI signal 36/279 (13%) 78/81 (96%) 0.0000 0.0023
Relationship to peritoneal
reflection
75/279 (26.9) 77/81 (95%) 0.0000 0.0024
T stage 261/279 (94%) 79/81 (98%) 0.2684 0.0167
If ≥ T3 Distance through muscularis
propria*
60/169 (36%) 54/58 (93%) 0.0000 0.0028
MRF MRF status 184/279 (66%) 78/81 (96%) 0.0000 0.0036
If threatened/involved, by
what*
111/118 (94%) 49/49 (100%) 0.1069 0.0125
Minimum distance to the
MRF*
60/108 (56%) 36/43 (84%) 0.0013 0.0063
Location closest to MRF 85/279 (31%) 58/81 (72%) 0.0000 0.0031
If ≥ T4 Which organs involved* 33/41 (81%) 42/42 (100%) 0.0024 0.0071
Nodes Nodal status 268/279 (96%) 80/81 (99%) 0.3125 0.0250
Location of involved nodes* 157/164 (96%) 50/51 (98%) 0.6835 0.0500
Radial location of mesorectal
nodal involvement*
81/156 (52%) 44/50 (88%) 0.0000 0.0045
Superior location of node
involvement*
25/156 (16%) 44/48 (92%) 0.0000 0.0025
EMVI EMVI status 144/279 (52%) 80/81 (99%) 0.0000 0.0026
EMVI radial and/or superior
location*
37/79 (47%) 34/36 (94%) 0.0000 0.0042
Metastases Metastatic status* 71/199 (36%) 36/45 (80%) 0.0000 0.0038
Overall predicted stage 249/279 (89%) 80/81 (99%) 0.0056 0.0083
*Tumour descriptors with appropriate report exclusions allowed depending on the tumour features (e.g. the absence of a distance through the muscularis
propria was considered acceptable for T1/T2 tumours or not stating which organs are involved by tumour with T1–3 staging, or radial location of wall
involvement for annular tumours)
MRF mesorectal fascia, EMVI extra-mural venous invasion
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11 tumour descriptors and did not assess the impact of tem-
plate reports; by comparison, in our study, we have assessed
360 reports and 22 tumour descriptors including an assess-
ment of the impact of template reports [21]. Here, it is shown
the beneficial impact of template reports is similar to that
observed in pathology reports for colorectal cancer [22–24].
Given that the majority of primary staging scans and reports
are produced in regional hospitals rather than teaching hospi-
tals, the same standards of reporting should be expected irre-
spective of the setting.
Alongside the significant improvement in the completeness
percentage score for template reports compared to free-text
reports, there was a reduction in spread of the interquartile
range for the template report groups, with a reduction in the
variability of template reports implying improved consistency
for inclusion of key tumour descriptors. The inclusion of an
increased number of tumour descriptors will inherently add
important negative findings. Although the absence of tumour
descriptors in free-text reports may imply a negative finding,
the clear documentation of these may be helpful for clinicians
and allow further studies assessing inter- and intra-radiologist
agreement and correlation with pathological findings.
Several primary staging report templates have been devel-
oped with subtle differences in the tumour descriptors collect-
ed [14, 15, 25–27]. Irrespective of the template, we have
assessed all of the key tumour descriptors included in each
template recommended by the European and American ab-
dominal imaging societies (ESGAR and SAR) [14, 15].
Although not acknowledged as key tumour descriptors, we
have also assessed reports for descriptive information regard-
ing the location of mesorectal fascia, metastatic lymph node
and extra-mural venous involvement as these are reported
locally to be helpful in surgical and radiotherapy planning.
Template reporting significantly improves tumour description
compared to free-text reporting styles, Table 3.
Despite a well-established prognostic link between tumour
involvement of the MRF being associated with worse clinical
outcomes due to the more frequent occurrence of a positive
CRM, it is included in only 65.9% of free-text reports com-
pared to 96.3% of template reports (p < 0.01). Subgroup anal-
ysis within this dataset, using only T3 or T4 tumours, shows
inclusion of tumour involvement of the MRF is still only
included in 81.1% of free-text reports compared to 100% of
template reports (p < 0.01). The influence on prognosis of
CRM involvement by the primary tumour compared to ve-
nous or lymphatic vessel invasion, or lymph nodes has not
been fully evaluated other than two relatively small studies
that demonstrated lymph node-CRM involvement had no im-
pact on local recurrence, in distinction from other tumour
components [28, 29]. However, these tumour descriptors are
recorded in the SAR guideline template [15]. We found there
was no difference in report inclusion of what aspect of the
primary tumour threatened the MRF in each report style. As
a potentially important variable to assess in relation to the
prognosis, its inclusion in template reports could help to better
understand its value.
Furthermore, there are subtle differences between the meth-
od of sub-categorisation for T3 tumours within the ESGAR
and SAR templates [14, 15]. The ESGAR template
dichotomises T3 tumours into two groups (either ≤ 5 mm or ≥
5 mm extra-mural growth beyond the muscularis propria)
[14]. By comparison, the SAR template uses four T3 sub-
categories (a, < 1 mm; b, < 5 mm; c, 5–15 mm or d, ≥
15mm) for tumour penetration beyond themuscularis propria.
Each system stratifies patients, which influences the neo-
adjuvant therapies offered based on prior studies
Fig. 1 Bar chart of completeness
scores (%) for each radiologist in
the study. Red bars represent
radiologists who have used
template reports and blue bars
radiologists that have used free-
text (prose) reports. Each cluster
of bars represents the radiologists
within each department. Analysis
of the completeness percentage
score for template reports com-
pared to free-text reports showed
a median of 96% inclusion of all
variables (IQR, 92–97%) com-
pared to median 57% inclusion of
all variables (IQR, 55–68%) re-
spectively, p = 0.039
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demonstrating the prognostic significance of the depth extra-
mural of tumour extension on locoregional recurrence [28, 30,
31]. There is conflicting evidence as to the precise depth that is
significant for an increased risk of locoregional recurrence,
either 5 mm or 10 mm beyond the muscularis propria [28,
30, 31]. However, irrespective of the sub-categorisation meth-
od used, this study demonstrates the use of template reports
significantly increases documentation of depth of invasion
beyond the muscularis propria (93.1% vs 35.5% inclusion of
T3 subcategories/depth in template vs free-text reports,
p < 0.01).
Accurately determining tumour involvement in lymph
nodes based on size and morphological appearance can be
difficult in rectal cancer MRI, but the description of
involved/potentially involved lymph nodes is undeniably
important [32]. In our population the use of a template did
not improve reporting on nodal status (96.1% inclusion in
free-text reports compared to 98.8% inclusion in template
reports; corrected p < 0.3125) or descriptions of intra- or
extra-mesorectal node location (95.7% inclusion in free-
text reports compared to 98.0% inclusion in template re-
ports; corrected p < 0.68). One limitation of our study is
that neither the free-text nor template reports assessed if
established criteria were applied to determine if nodes
were involved with tumour or not. Template reports allow
more categorisation of the rationale for determining nodal
status; for example based on size and/or other morpholog-
ical features as in the ESGAR and SAR consensus tem-
plates [14, 15]. Further assessment of the features and
pathological correlation may improve radiologist and cli-
nician confidence in determining which nodes are in-
volved with malignant disease.
The retrospective design of this study assesses the current
reporting standards of primary staging for rectal cancer in
routine clinical practice in 2017 provided by subspecialised
GI radiologists. It highlights potential areas for quality im-
provement and standardisation through the use of template
reports despite subspecialised GI training for radiologists
reporting large volumes of rectal cancer staging MRI.
Unlike the study by Siddiqui et al, the existing use of the
template reports in two centres (by nine radiologists) elimi-
nates the potential bias arising from the introduction and as-
sociated training with template reports when assessing their
impact [26, 33]. However, to maximise the benefits of tem-
plate reports in our population, their introduction to free-text
reporting centres should occur in conjunction with appropriate
training that would reiterate the importance of key tumour
descriptors. Furthermore, here we have demonstrated that
template reports include more tumour descriptors than free-
text reports. Further work is required to demonstrate that re-
port accuracy and inter-radiologist agreement is maintained or
even improves with standardised descriptive terms found in
template reports.
A limitation of this study is the relatively small number of
template reports used within two trusts, compared to free-text
reports. Although this might increase the likelihood of a type 1
statistical error in assessing the impact of template reports, we
have primarily assessed the current standard of primary stag-
ing reports irrespective of template use. Additionally, because
our findings are replicated across multiple tumour descriptors
and show strong statistical significance after correction, mul-
tiple type 1 errors are unlikely.
Primary staging rectal cancer MRI reports in routine clinical
practice do not meet published standards with multiple key tu-
mour descriptors omitted from reports. A standardised report
template results in a significant increase in the inclusion of key
tumour descriptors for subspecialised GI radiologists. This study
provides further support for the routine use of template reports to
improve reporting standards and outcomes in rectal cancer.
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